Clinical Trials Logo

Filter by:
NCT ID: NCT05716113 Recruiting - Neoplasms Clinical Trials

CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL

Start date: February 15, 2023
Phase: Early Phase 1
Study type: Interventional

This is a single-arm, open-label, single-center, phase I study. The primary objective is to evaluate the safety of CD7 CAR-T therapy for patients with CD7-positive relapsed or refractory T-ALL/LBL, and to evaluate the pharmacokinetics of CD7 CAR-T in patients.

NCT ID: NCT05716087 Recruiting - Clinical trials for Mantle Cell Lymphoma (MCL)

A Study of LP-168 in Participants With Relapse or Refractory Mantle Cell Lymphoma

Start date: February 21, 2023
Phase: Phase 2
Study type: Interventional

This is an open-label, single arm, multi-center Phase 2 study of oral LP-168 in patients with mantle cell lymphoma who are failed or relapsed after remission or intolerated to Bruton's tyrosine kinase (BTK) inhibitor.

NCT ID: NCT05716035 Recruiting - Clinical trials for Myasthenia Gravis, Generalized

Open-Label Extension of Tocilizumab in Subjects With Generalized Myasthenia Gravis

tMG-E
Start date: April 1, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

To evaluate the safety and efficacy of tocilizumab in the treatment of generalized myasthenia gravis (gMG) as an extension study for the participants who previously completed Study tMG(NCT05067348).

NCT ID: NCT05715996 Recruiting - Lung Cancer Clinical Trials

Application of Mixed Reality Technique for Percutaneous Lung Nodule Localization: A Prospective, Randomized, Controlled Trial

MR
Start date: May 23, 2023
Phase: N/A
Study type: Interventional

With the popularization of CT screening, the detection rate of small lung nodules has greatly increased. Therefore, the clinical thoracoscopic lung nodule biopsy and sub-lobectomy for radical resection of lung cancer are greatly required. Accurate resection of lung nodule depends on precise localization of pulmonary nodules. However, preoperative CT-guided Hook- wire positioning under local anesthesia, which is the current primary localization method, requires high equipment and expense, and may cause physical and mental trauma to the patient. Augmented reality (AR) is an innovative technology that superimpose a virtual scene into the real environment by fusing images, videos, or computer-generated models with patients during surgical operations. It can visually display the anatomical structures of organs or lesions, which significantly improves surgical efficiency. This project intends to use AR technology to localize the solitary pulmonary nodule (SPN) before surgery, compared with CT-guided Hook-wire localization. Compared with the localization of SPNs under CT guidance, AR-assisted localization technology apparently is less time-consuming and can be performed immediately before surgery under general anesthesia, lessening pain, reduce costs of time and equipment, increase the success rate of sub-lobectomy, and improve the overall efficiency of surgical treatment of pulmonary nodules.

NCT ID: NCT05715931 Recruiting - Clinical trials for HER2-positive Gastric Cancer

Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

Start date: February 28, 2023
Phase: Phase 2
Study type: Interventional

This study is a prospective, single arm, multi-center phase II clinical trial designed to evaluate the efficacy and safety of perioperative chemotherapy with FLOT regimen and trastuzumab in combination with toripalimab in participants with resectable HER2 positive locally advanced gastric or esophagogastric junction adenocarcinoma.

NCT ID: NCT05715788 Recruiting - Clinical trials for Respiratory Distress Syndrome

Prone Positioning vs. Prone Positioning and NO Inhalation in COVID-19 ARDS.

Start date: December 21, 2022
Phase:
Study type: Observational

The investigators aim to investigate the effects of prone positioning and prone positioning with NO inhalation for COVID-19 patients with ARDS.

NCT ID: NCT05715762 Recruiting - COVID-19 Clinical Trials

Determine the Effects of Prone Positioning and NO in COVID-19 ARDS by EIT

Start date: December 21, 2022
Phase:
Study type: Observational [Patient Registry]

We aims to investigate the effects of prone positioning and nitric oxide inhalation in adult patients who is diagnosed with COVID-19 associated acute respiratory distress syndrome by electrical impedance tomography.

NCT ID: NCT05715710 Recruiting - Clinical trials for Cerebral Small Vessel Disease

Correlation Between Deep Medullary Veins and Cognitive Dysfunction in Cerebral Small Vessel Disease

Start date: January 1, 2022
Phase:
Study type: Observational

This study aims to obtain the characteristics of cognitive impairment and imaging characteristics of patients with Cerebral small vessel disease (CSVD) through comprehensive and standardized neuropsychological assessment and multimodal imaging examination. The focus is to obtain the characteristics of cognitive impairment and imaging characteristics of patients with CSVD through 3.0T MRI SWI sequence. deep medullary veins (DMVs) were measured. To compare the demographic data, hematological indexes, imaging scores and the number of DMVs between CSVD groups with and without cognitive impairment, and to explore the correlation between deep medullary veins and cognitive dysfunction in cerebral small vessel disease.

NCT ID: NCT05715697 Recruiting - Clinical trials for Heart Failure With Preserved Ejection Fraction

Renal Denervation in Patients With Chronic Heart Failure With Preserved Ejection Fraction

RDN-HFPEF
Start date: September 1, 2023
Phase: N/A
Study type: Interventional

This study aims to explore the potential of RDN as a therapy for HFpEF in a Prospective, Multicenter, Randomized, Blinded, Sham-controlled Study.

NCT ID: NCT05715658 Recruiting - Health, Subjective Clinical Trials

Pharmacokinetic Study to Evaluate Dabigatran Etexilate in Elderly Subjects

Start date: August 15, 2022
Phase: N/A
Study type: Interventional

This study intends to collect blood samples of adult healthy subjects, elderly healthy subjects and elderly patients with atrial fibrillation after taking dabigatran etexilate for pharmacokinetics and other studies, aiming to reveal the effect of dabigatran etexilate in Chinese elderly population. Pharmacokinetic profile and biomarker concentration levels; fecal samples were collected for gut microbiota studies to further explore potential mechanisms. The results of the study may provide reference for the precision medicine of dabigatran etexilate and other drugs in the elderly population or the development of new clinical drugs.